Renaissance Technologies’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
+94,000
| New | +$169K | ﹤0.01% | 3201 |
|
|
2024
Q4 | – | Sell |
-53,264
| Closed | -$94.8K | – | 3692 |
|
|
2024
Q3 | $94.8K | Sell |
53,264
-65,436
| -55% | -$116K | ﹤0.01% | 3267 |
|
|
2024
Q2 | $152K | Buy |
118,700
+72,000
| +154% | +$92.2K | ﹤0.01% | 3103 |
|
|
2024
Q1 | $176K | Buy |
46,700
+3,900
| +9% | +$14.7K | ﹤0.01% | 3254 |
|
|
2023
Q4 | $140K | Sell |
42,800
-4,100
| -9% | -$13.4K | ﹤0.01% | 3227 |
|
|
2023
Q3 | $154K | Sell |
46,900
-700
| -1% | -$2.3K | ﹤0.01% | 3152 |
|
|
2023
Q2 | $213K | Buy |
47,600
+8,900
| +23% | +$39.8K | ﹤0.01% | 3277 |
|
|
2023
Q1 | $187K | Buy |
38,700
+5,500
| +17% | +$26.6K | ﹤0.01% | 3300 |
|
|
2022
Q4 | $104K | Sell |
33,200
-200
| -0.6% | -$627 | ﹤0.01% | 3605 |
|
|
2022
Q3 | $109K | Buy |
33,400
+300
| +0.9% | +$979 | ﹤0.01% | 3565 |
|
|
2022
Q2 | $119K | Buy |
+33,100
| New | +$119K | ﹤0.01% | 3801 |
|